Skip to content

A clinical evaluation research for the treatment of major depression by integrated Disease with Zheng of TCM method

A clinical evaluation research for the treatment of major depression by integrated Disease with Zheng of TCM method

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008327
Enrollment
Unknown
Registered
2016-04-20
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depression disease

Interventions

A:Escitalopram
B:Escitalopram
A:Liver resolve depression particles

Sponsors

southern medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) in accordance with the conventional disease diagnosis and treatment of TCM in Shanghai (second edition) and dsm-iv psychiatric diagnosis standard in the United States; (2) 24 Hamilton depression rating scale score of n p 20 points, namely the clinical - severe type; (3) aged 18 to 45 years old; (4) at least 1 week before the treatment was not used antidepressant drugs (including western medicine and traditional Chinese medicine) and other psychiatric drugs, or have been used but the cleaning at least 1 weeks; After two different types of antidepressants or at least more than 6 weeks, nearly 1 week is invalid, can maintain the original drug dosage into the group; (5) cultural degree for junior high school above; (6) course of more than 2 weeks; (7) right-handed; (8) no contraindications to MRI scanning; (9) with the approval of the hospital ethics committee, volunteer to participate in, and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) a history of schizophrenia, alcohol and drug dependence; (2) has a history of organic brain disease and endocrine diseases; (3) through inspection, heart, liver and kidney was abnormal urinalysis performed; (4) have a planned pregnancy, pregnancy and lactation women; (5) has a history of mania or hypomania attacks, past electroconvulsive therapy.

Design outcomes

Primary

MeasureTime frame
HAMD-17;

Countries

China

Contacts

Public ContactWang Weidong

Guang'an'men Hospital

prof_wwd@126.com+86 13910524637

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026